Zhang, Shali <br/><br/>
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways.  [electronic resource] 

 -  Anticancer research  Oct 2011 
 - 3259-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anthracenes--pharmacology<br/>Benzenesulfonates--pharmacology<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chromones--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Enzyme Activation--drug effects<br/>Fatty Acids, Monounsaturated--pharmacology<br/>Fluvastatin<br/>Humans<br/>Indoles--pharmacology<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Melanoma--enzymology<br/>Morpholines--pharmacology<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Pyridines--pharmacology<br/>Signal Transduction--drug effects<br/>Sorafenib